Watch: In the midst of an opioid epidemic, drug testing is exploding
Citing the high risk of addiction when prescribing opioids, physicians are requiring drug tests in record numbers. The testing market has since exploded to $8.5 billion annually in just a few short years. Now patients who aren’t addicted are getting saddled with surprise $15,000+ bills. The labs responsible are coming under scrutiny for the suspect…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.
Citing the high risk of addiction when prescribing opioids, physicians are requiring drug tests in record numbers. The testing market has since exploded to $8.5 billion annually in just a few short years. Now patients who aren’t addicted are getting saddled with surprise $15,000+ bills. The labs responsible are coming under scrutiny for the suspect practice, though action has yet to be taken.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
